HL
VRTX icon

Harding Loevner’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$317M Buy
711,611
+13,152
+2% +$5.86M 2.13% 16
2025
Q1
$339M Sell
698,459
-125,168
-15% -$60.7M 2.59% 13
2024
Q4
$332M Sell
823,627
-328,998
-29% -$132M 2.24% 14
2024
Q3
$536M Sell
1,152,625
-31,783
-3% -$14.8M 3.09% 10
2024
Q2
$555M Sell
1,184,408
-38,630
-3% -$18.1M 3.06% 10
2024
Q1
$511M Sell
1,223,038
-98,191
-7% -$41M 3.16% 8
2023
Q4
$539M Sell
1,321,229
-25,522
-2% -$10.4M 3.02% 7
2023
Q3
$468M Sell
1,346,751
-191,519
-12% -$66.6M 3.09% 7
2023
Q2
$541M Sell
1,538,270
-288,354
-16% -$101M 3.16% 7
2023
Q1
$576M Sell
1,826,624
-13,897
-0.8% -$4.38M 3.28% 7
2022
Q4
$532M Buy
1,840,521
+200,704
+12% +$58M 3.06% 8
2022
Q3
$475M Sell
1,639,817
-93,874
-5% -$27.2M 3.11% 7
2022
Q2
$489M Sell
1,733,691
-35,585
-2% -$10M 3.01% 8
2022
Q1
$417M Sell
1,769,276
-112,595
-6% -$26.6M 2.3% 13
2021
Q4
$413M Sell
1,881,871
-29,232
-2% -$6.42M 1.58% 26
2021
Q3
$347M Sell
1,911,103
-87,975
-4% -$16M 1.38% 28
2021
Q2
$403M Buy
1,999,078
+15,989
+0.8% +$3.22M 1.52% 24
2021
Q1
$426M Sell
1,983,089
-60,006
-3% -$12.9M 1.67% 22
2020
Q4
$483M Buy
2,043,095
+42,554
+2% +$10.1M 2% 17
2020
Q3
$544M Sell
2,000,541
-21,226
-1% -$5.78M 1.96% 12
2020
Q2
$587M Sell
2,021,767
-25,507
-1% -$7.4M 2.81% 9
2020
Q1
$487M Sell
2,047,274
-44,382
-2% -$10.6M 2.72% 9
2019
Q4
$458M Sell
2,091,656
-231,426
-10% -$50.7M 2.04% 15
2019
Q3
$394M Buy
2,323,082
+1,582,711
+214% +$268M 1.86% 21
2019
Q2
$136M Sell
740,371
-11,673
-2% -$2.14M 0.62% 54
2019
Q1
$138M Buy
752,044
+751,975
+1,089,819% +$138M 0.65% 56
2018
Q4
$11K Buy
+69
New +$11K ﹤0.01% 135